ArticleClinical transplantation2026
Regional Variation in Transplant Utilization and Agonal Times among Donation after Circulatory Death Lung Donors in the United States.
Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Regional Variation in Transplant Utilization and Agonal Times among Donation after Circulatory Death Lung Donors in the United States.Clinical transplantation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUtilization of donation after circulatory death (DCD) donors in lung transplant in the United States lags when compared to other countries. We sought to evaluate geographical variation in the percentage of donation after circulatory death donors, conversion to lung transplant, agonal times, and consent for donation.
methodsWe queried the United Network for Organ Sharing database (2018-2023) to identify DCD donors and compared across organ procurement organizations (OPO). We illustrated the geographical variation in the location of transplant centers using DCDs, DCD donors used for solid organ transplant/ lung transplant, and median agonal time. Also, a special mapping was performed for the geographical difference of the refusal code utilization for declining the DCD lungs.
resultsThere were 889 DCD donors where at least one lung was used for transplant, while 13,030 (75.6%) resulted in other solid organ transplants. The utilization of DCD organs was >65% and equal across the US, while DCD transplant centers were predominantly located in 5 states. The lower utilization of DCD lungs, up to 12.7% was equally observed in each state. Over 75%, of DCDs had an agonal time ≤ 30 min in most states except South Florida, eastern Pennsylvania and Colorado/Wyoming. The map colored based on the refusal code categories also showed the geographical differences.
conclusionAs we continue to increase DCD lung utilization in the United States, better understanding of geographical barriers, adopting universal protocols in DCD organ donation and palliative care will hopefully lead to better utilization of organs from DCD donors, thereby increasing the number of transplants and decreasing organ wait times.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.